Why the study?
What are the characteristic electrocardiographic differences of Class 1a, 1b, and 1c antiarrhythmic drugs during sinus rhythm and paced rates?
What are the characteristic electrocardiographic differences of Class 1a, 1b, and 1c antiarrhythmic drugs during sinus rhythm and paced rates?
Class 1a, 1b, and 1c antiarrhythmic drugs exhibit distinct effects on ECG intervals during sinus rhythm and pacing, supporting their subclassification.
ECG differentiation of Class I agents may guide selection; leaves open validation beyond case reports.
Class 1 antiarrhythmic drugs have been subdivided into 1a, 1b and 1c according to their effect on the action potential duration. The effects on the surface electrocardiogram of one drug from each subgroup were investigated in nine patients. Electrocardiographic recordings were taken during sinus rhythm and at identical atrial and ventricular paced rates. Disopyramide (1a) significantly prolonged the QT interval during sinus rhythm and at the identical paced rates, by increasing both the QRS duration and JT interval. Lignocaine (1b) significantly reduced the QT interval during sinus rhythm and at the identical paced rates, by reducing the JT interval. Lignocaine had no effect on the QRS duration. Flecainide (1c) significantly prolonged the QRS duration during sinus rhythm, but not the QTc. However the QT interval at the paced rates prolonged significantly, due entirely to an increase of the QRS duration. Flecainide had no effect on the JT interval. These characteristic electrocardiographic differences support the differentiation of class 1 drugs into three separate subgroups.
No takes yet. Share an insight, caveat, or question.
Milne et al. (1984) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: